The Period From 2026 To Witness Substantial Growth Of Gastrointestinal Infection Testing Market At A CAGR Of 5.1%
The Gastrointestinal Infection Testing Market Share is estimated to be reaching US$ 490.2 Million at a CAGR of 5.1% from 2026. With advanced digitization driving the healthcare industry, the concept of a “global village” has become a reality. As such, medical treatment could be sought to transcend the geographical barriers, which would form the focal point of the healthcare industry going forward.
Gastrointestinal (GI) infections
are one of the most common infections in primary care. According to NCBI
(National Center for Biotechnology Information), around 200 Mn GI infections
occur in the U.S. annually. To detect bacteria, virus and parasites,
gastrointestinal infection testing is done.
The molecular tool is used for
fast discovery of bacteria in clinical specimens and allows early and clear
laboratory validation of related diseases. Since the past few years, real-time
PCR tests have been widely developed in clinical microbiology labs for routine
gastrointestinal infection testing of infectious diseases, such as bacterial,
viral and parasitic diseases.
Get
Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/17314
Company
Profiles
·
Becton,
Dickinson and Company (BD)
·
Thermo
Fisher Scientific Inc.
·
Bio-Rad
Laboratories Inc.
·
Luminex
Corporation
·
Hoffmann-La
Roche Ltd.
·
bioMérieux
SA
·
Quidel
Corporation
·
Illumina,
Inc.
·
Seegene
Inc
·
Genetic
Signatures
·
Others.
This factor will boost the growth
of the gastrointestinal infection testing market during the forecast period.
According to the latest report published by the company, the global
gastrointestinal infection testing market is projected to account for
over US$ 490.2 Mn, in terms of value, by 2026 end. The
report further projects that the gastrointestinal infection testing market will
grow at a CAGR of 5.1% through 2026.
Growing
Usage of Sophisticated Infection Detection Panels and Infectious Testing Kits
to Give a Boost to the Gastrointestinal Infection Testing Market
Diarrhea is one of the leading
causes of deaths. According to WHO, diarrhea kills around 525 Mn children aged
5 years or less every year. Gastrointestinal infection testing is done using
PCR systems that provide a quick valuation of gene mutations or the presence of
antibiotic resistance genes.
This factor will increase the
growth of the gastrointestinal infection testing market during the forecast
period. That apart, increasing healthcare expenditure by governments has
enabled the usage of sophisticated infection detection panels and infectious testing
kits in hospitals, diagnostic laboratories and institutes.
Get To
Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/17314
This factor, in particular, is
likely to play an instrumental role in driving the growth of the
gastrointestinal infection testing market during the forecast period.
Asia
Pacific Excluding China to Register Highest Growth Rate
Stringent rules and regulations
set by the U.S. Food and Drug Administration (FDA) may hinder the growth of the
gastrointestinal infection testing market. The North America gastrointestinal
infection testing market is expected to give a boost to the growth of the
gastrointestinal infection testing market due to increasing healthcare spending
and government initiatives to spread awareness and availability of better
gastrointestinal infection testing options in the region.
The Asia Pacific ex. China
gastrointestinal infection testing market is expected to grow at highest CAGR
owing to increasing patient pool due to unhygienic lifestyle and improper
sanitation facilities in this region. The Asia Pacific ex. China
gastrointestinal infection testing market is estimated to create incremental $
opportunity worth US$ 41.9 Mn between 2018 and 2026.
Access
Full Report @ https://www.persistencemarketresearch.com/checkout/17314
Gastrointestinal
Infection Testing Market: Segmental Analysis
The global gastrointestinal
infection testing market has been segmented by disease strains, product type
and end user. The gastrointestinal infection testing market has been segmented
by disease strains into bacterial strains, viral strains and parasitic strains.
Based on product type, the
gastrointestinal infection testing market is segmented into reagent kits,
sequencing kits and equipment. In terms of revenue, the reagent kits segment is
expected to hold major share during the forecast period due to its user-friendly
nature and accurate detection of foreign agents.
On the basis of end users, the
gastrointestinal infection testing market is segmented into hospitals,
clinics/medical centers, diagnostic laboratories and research institutes. The
hospital segment is expected to show high revenue growth as an increasing
number of people are getting hospitalized due to increasing gastrointestinal
infections.
About Us:
Persistence Market Research is
here to provide companies a one-stop solution with regards to bettering
customer experience. It does engage in gathering appropriate feedback after
getting through personalized customer interactions for adding value to
customers’ experience by acting as the “missing” link between “customer
relationships” and “business outcomes’. The best possible returns are assured
therein.
Contact
Us:
Persistence
Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com
Comments
Post a Comment